Furthermore, it has been reported to interact with glypican 3 (GPC3) in liver cancer cells, leading to activation of insulin-like growth factor 1 receptor (IGF1R) signaling, which is involved in tumorigenesis [4,12]. This evidence concerns the gene GPC3 and liver cancer.